The biomarker development study consisted of two parts: discovery and validation. The first part was the discovery and verification phase of biomarkers using two different platforms: transcriptomic an
The dataset encompasses systematically extracted biomarker, clinical, and methodological data from 28 studies (2016-2025) evaluating exosomes and extracellular vesicles (EVs) across dermatologic and s
BackgroundPancreatic cancer (PC) has a dismal prognosis due to its insidious early symptoms and poor early detection rate. Exosomes can be released by various cell types and tend to be a potential nov